256 related articles for article (PubMed ID: 12136128)
1. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia.
McClain DA; Lubas WA; Cooksey RC; Hazel M; Parker GJ; Love DC; Hanover JA
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10695-9. PubMed ID: 12136128
[TBL] [Abstract][Full Text] [Related]
2. Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance.
Hazel M; Cooksey RC; Jones D; Parker G; Neidigh JL; Witherbee B; Gulve EA; McClain DA
Endocrinology; 2004 May; 145(5):2118-28. PubMed ID: 14684615
[TBL] [Abstract][Full Text] [Related]
3. Role of hexosamines in insulin resistance and nutrient sensing in human adipose and muscle tissue.
Pouwels MJ; Tack CJ; Span PN; Olthaar AJ; Sweep CG; Huvers FC; Lutterman JA; Hermus AR
J Clin Endocrinol Metab; 2004 Oct; 89(10):5132-7. PubMed ID: 15472217
[TBL] [Abstract][Full Text] [Related]
4. UDP-N-acetylglucosamine transferase and glutamine: fructose 6-phosphate amidotransferase activities in insulin-sensitive tissues.
Yki-Järvinen H; Vogt C; Iozzo P; Pipek R; Daniels MC; Virkamäki A; Mäkimattila S; Mandarino L; DeFronzo RA; McClain D; Gottschalk WK
Diabetologia; 1997 Jan; 40(1):76-81. PubMed ID: 9028721
[TBL] [Abstract][Full Text] [Related]
5. Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob/ob mice.
Buse MG; Robinson KA; Gettys TW; McMahon EG; Gulve EA
Am J Physiol; 1997 Jun; 272(6 Pt 1):E1080-8. PubMed ID: 9227455
[TBL] [Abstract][Full Text] [Related]
6. Muscle uridine diphosphate-hexosamines do not decrease despite correction of hyperglycemia-induced insulin resistance in type 2 diabetes.
Pouwels MJ; Span PN; Tack CJ; Olthaar AJ; Sweep CG; van Engelen BG; de Jong JG; Lutterman JA; Hermus AR
J Clin Endocrinol Metab; 2002 Nov; 87(11):5179-84. PubMed ID: 12414889
[TBL] [Abstract][Full Text] [Related]
7. The hexosamine signaling pathway: deciphering the "O-GlcNAc code".
Love DC; Hanover JA
Sci STKE; 2005 Nov; 2005(312):re13. PubMed ID: 16317114
[TBL] [Abstract][Full Text] [Related]
8. Exploring levels of hexosamine biosynthesis pathway intermediates and protein kinase C isoforms in muscle and fat tissue of Zucker Diabetic Fatty rats.
Bosch RR; Janssen SW; Span PN; Olthaar A; van Emst-de Vries SE; Willems PH; Martens J M G; Hermus AR; Sweep CC
Endocrine; 2003 Apr; 20(3):247-52. PubMed ID: 12721503
[TBL] [Abstract][Full Text] [Related]
9. Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
[TBL] [Abstract][Full Text] [Related]
10. Adipocytes with increased hexosamine flux exhibit insulin resistance, increased glucose uptake, and increased synthesis and storage of lipid.
McClain DA; Hazel M; Parker G; Cooksey RC
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E973-9. PubMed ID: 15613679
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle O-GlcNAc transferase is important for muscle energy homeostasis and whole-body insulin sensitivity.
Shi H; Munk A; Nielsen TS; Daughtry MR; Larsson L; Li S; Høyer KF; Geisler HW; Sulek K; Kjøbsted R; Fisher T; Andersen MM; Shen Z; Hansen UK; England EM; Cheng Z; Højlund K; Wojtaszewski JFP; Yang X; Hulver MW; Helm RF; Treebak JT; Gerrard DE
Mol Metab; 2018 May; 11():160-177. PubMed ID: 29525407
[TBL] [Abstract][Full Text] [Related]
12. Role of the glucosamine pathway in fat-induced insulin resistance.
Hawkins M; Barzilai N; Liu R; Hu M; Chen W; Rossetti L
J Clin Invest; 1997 May; 99(9):2173-82. PubMed ID: 9151789
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Reprogramming by Hexosamine Biosynthetic and Golgi N-Glycan Branching Pathways.
Ryczko MC; Pawling J; Chen R; Abdel Rahman AM; Yau K; Copeland JK; Zhang C; Surendra A; Guttman DS; Figeys D; Dennis JW
Sci Rep; 2016 Mar; 6():23043. PubMed ID: 26972830
[TBL] [Abstract][Full Text] [Related]
14. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.
Kim JK; Zisman A; Fillmore JJ; Peroni OD; Kotani K; Perret P; Zong H; Dong J; Kahn CR; Kahn BB; Shulman GI
J Clin Invest; 2001 Jul; 108(1):153-60. PubMed ID: 11435467
[TBL] [Abstract][Full Text] [Related]
15. Development and comparison of two 3T3-L1 adipocyte models of insulin resistance: increased glucose flux vs glucosamine treatment.
Ross SA; Chen X; Hope HR; Sun S; McMahon EG; Broschat K; Gulve EA
Biochem Biophys Res Commun; 2000 Jul; 273(3):1033-41. PubMed ID: 10891367
[TBL] [Abstract][Full Text] [Related]
16. N-3 polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle.
Taouis M; Dagou C; Ster C; Durand G; Pinault M; Delarue J
Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E664-71. PubMed ID: 11832371
[TBL] [Abstract][Full Text] [Related]
17. The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake.
Hawkins M; Angelov I; Liu R; Barzilai N; Rossetti L
J Biol Chem; 1997 Feb; 272(8):4889-95. PubMed ID: 9030547
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice overexpressing the rate-limiting enzyme for hexosamine synthesis in skeletal muscle or adipose tissue exhibit total body insulin resistance.
Cooksey RC; McClain DA
Ann N Y Acad Sci; 2002 Jun; 967():102-11. PubMed ID: 12079840
[TBL] [Abstract][Full Text] [Related]
19. Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles.
Buse MG; Robinson KA; Marshall BA; Hresko RC; Mueckler MM
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E241-50. PubMed ID: 12110528
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice.
Shiuchi T; Iwai M; Li HS; Wu L; Min LJ; Li JM; Okumura M; Cui TX; Horiuchi M
Hypertension; 2004 May; 43(5):1003-10. PubMed ID: 15037562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]